March 25, 2026 POLAR Trial: Precision Immunotherapy Outcomes in Metastatic Pancreatic Cancer by HRD Status
March 1, 2026 Multiple Myeloma Research: Collaborative Study by Dana-Farber & San Raffaele Institutes
